Stephen Pelton
Pediatric Infectious Diseases · Boston, MANPI 1891777223
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $268,347 of the $387,988 with a category attached, or 69.2%. 6 manufacturers reported payments, led by Pfizer at 47.2% of the total. Among pediatric infectious diseases clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $2639.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$183K
- Merck$64K
- Sanofi US Services Inc.$58K
- Seqirus USA Inc$46K
- Sanofi Pasteur Inc.$30K
- GSK$6K
Across 24 payments — averaging $106,637 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.5M
- Merck$757K
- GSK$281K
- Sanofi Pasteur Inc.$67K
What the payments were for
- Consulting fees$268,34769%
- Speaking & faculty fees$94,28124%
- Travel & lodging$24,2996%
- Food & beverage$1,0610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer(2 entities) | 41 | $183,191 |
| Merck | 57 | $64,466 |
| Sanofi US Services Inc. | 2 | $57,900 |
| Seqirus USA Inc | 17 | $46,184 |
| Sanofi Pasteur Inc. | 22 | $30,274 |
| GSK | 8 | $5,973 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVNAR 20$92,439
- PREVNAR - 13$65,928
- MENACYW CONJUGATE VACCINE$8,610
- PNEUMOVAX 23$7,669
- FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)$6,039
- V114$1,275
- NO PRODUCT DISCUSSED$673
How this compares
$387,988 in reported general payments places this provider in the 95th percentile of 29 pediatric infectious diseases providers in Massachusetts.
See all pediatric infectious diseases providers in Massachusetts →
Other pediatric infectious diseases in Boston
- Rotem LapidotBoston$120K
- Richard MalleyBoston$115K
- Ofer LevyBoston$41K
- Elizabeth BarnettBoston$8K
- Jerome KleinBoston$3K
- Elizabeth MoultonBoston$2K
- Karen OcwiejaBoston$990
- Sandra BurchettBoston$872
- Steven SiegelBoston$703
- Asim AhmedBoston$431
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.